Moreover, a lysine methyltransferase, EZH2 as a part of the EZH2-containing PRC2 complex, maintain gene silencing through hypermethylation of tumor suppressors [109,110], and p-AKT-induced EZH enhances tumor progression through activation and methylation of STAT3 by direct association [111]. The gene discussed is STAT3; the disease is neoplasm.